Aurobindo Pharma Shareholding

Aurobindo Pharma Ltd Shareholding Pattern

The Aurobindo Pharma Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Aurobindo Pharma Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Aurobindo Pharma Ltd (NSE: AUROPHARMA, BSE: 524804) operates in the Health technology sector and Pharmaceuticals: other industry. Monitoring the Aurobindo Pharma Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Aurobindo Pharma Ltd Shareholding Pattern (Latest)

The latest Aurobindo Pharma Ltd shareholding for Dec 2025 is:

• Promoters: 51.82%
• FII: 13.94%
• DII: 27.68%
• Public: 6.55%
• Government: 0%

Promoter holding in Aurobindo Pharma Ltd remains stable, reflecting consistent long-term commitment.

Aurobindo Pharma Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Aurobindo Pharma Ltd.

• Dec 2025: 51.82%
• Sept 2025: 51.82%
• Jun 2025: 51.82%
• Mar 2025: 51.82%
• Dec 2024: 51.82%

Promoter stake remains largely stable, showing consistent ownership structure.

Aurobindo Pharma Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Aurobindo Pharma Ltd.

• Dec 2025: 13.94%
• Sept 2025: 14.21%
• Jun 2025: 14.37%
• Mar 2025: 15.33%
• Dec 2024: 16.29%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Aurobindo Pharma Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Dec 2025: 27.68%
• Sept 2025: 27.60%
• Jun 2025: 26.93%
• Mar 2025: 26.23%
• Dec 2024: 25.20%

DII stake in Aurobindo Pharma Ltd has increased over time, indicating growing domestic institutional confidence.

Aurobindo Pharma Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Dec 2025: 6.55%
• Sept 2025: 6.38%
• Jun 2025: 6.87%
• Mar 2025: 6.61%
• Dec 2024: 6.69%

Public participation in Aurobindo Pharma Ltd has increased, indicating rising retail investor interest.

Aurobindo Pharma Ltd Government Holding

Government holding in Aurobindo Pharma Ltd currently stands at 0%.

Aurobindo Pharma Ltd operates without significant government ownership.

Aurobindo Pharma Ltd Shareholding Analysis Summary

The Aurobindo Pharma Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Aurobindo Pharma Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.

Regular monitoring of the Aurobindo Pharma Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.